Cobalis Corporation
COBALIS COMPANY NEWS 2005

The following are recent important news releases by and about Cobalis, and its premier allergy prevention product PreHistin™:

Note: You will need Adobe Acrobat Reader installed to view the document. Click here to download Adobe Acrobat Reader.

Date   Description Downloads
12/01/05   Cobalis Adds CFO to Management Team e e Acrobat pdf file
11/02/05   Cobalis PreHistin™ to be Granted European Union Patent  
Acrobat pdf file
10/27/05   Cobalis PreHistin™ Significantly Reduces Allergy Symptoms In 714 Patient Phase III Clinical Trial     Acrobat pdf file
09/22/05   Legal Opinion Reinforces Cobalis Patent   Acrobat pdf file
03/30/05   Cobalis Appoints Cappello Capital Corp. as Exclusive Strategic Advisor and Investment Banker     Acrobat pdf file
03/22/05   Cobalis Signs Agreement With Trendtrade International to Commence Marketing of PreHistin™ in Australia     Acrobat pdf file
01/27/05   Cobalis Corp. Completes First Phase III Clinical Study With 715 Patients     Acrobat pdf file
 

IMPORTANT NOTICE:
The FDA has not completed evaluation of PreHistin™, and the information and statements contained in this web site are intended for informational purposes only. They are not meant to imply a cure or approved treatment for any disease or condition. You are encouraged to consult your physician for any healthcare questions or concerns you may have about your allergies.